Ligand validation:3HY5

RET: RETINAL

RET is a Ligand Of Interest in 3HY5 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3HY5_RET_A_400	7%	0%	0.446	0.907	6.23	3.52	12	14	4	0	100%	1
4CJ6_RET_A_1307	63%	40%	0.126	0.922	0.76	1.55	-	4	0	0	100%	1
3HX3_RET_A_400	56%	6%	0.116	0.885	0.83	4.03	-	16	0	0	100%	1
4CIZ_RET_A_1307	7%	62%	0.417	0.944	0.59	0.86	-	1	0	0	67%	0.6667
3UTY_RET_A_301	100%	5%	0.028	0.992	2.48	2.7	6	12	2	0	100%	0.9524
3UTX_RET_B_301	100%	6%	0.042	0.988	2.42	2.7	5	12	4	0	100%	0.9524
7XJE_RET_A_301	99%	6%	0.048	0.983	1.99	2.98	4	14	1	0	100%	0.9524
7XJC_RET_A_301	97%	10%	0.067	0.98	1.93	2.43	2	14	0	0	100%	0.7752
7XJD_RET_A_301	97%	10%	0.06	0.972	1.93	2.42	2	14	0	0	100%	0.9524

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.